Pre-IPO
Hark has launched its AI assistant, Hark Pro, for everyone
Last week, Hark—a deal we opened to our investors at the end of September—launched its first application for a general audience. Hark Pro is available for fr...
Pre-IPO
Pre-IPO investment opportunities and analysis
Pre-IPO
Johns Hopkins has selected OpenEvidence, which is already used by 1.12 million medical professionals in the U.S.
Johns Hopkins Medicine is launching a partnership with OpenEvidence focused on clinical practice and physician training, reports Fierce Healthcare.
Pre-IPO
Pre-money and post-money: why a single round has two valuations
In August, Form Energy closed a $750 million funding round, and media outlets differed in their valuations: some reported $1.75 billion, while others cited "...
Pre-IPO
Lambda raises the bar ahead of IPO: funding round of up to $4 billion at a $14.5 billion valuation
Great news for our investors who participated in the project back in 2023 or later!
Pre-IPO
OpenEvidence and Anthropic launch medical AI in 100 countries
Anthropic and OpenEvidence are set to provide doctors in approximately 100 low- and middle-income countries with free access to an AI-powered clinical decisi...
Pre-IPO
New Hark Deal: Figure Founder’s AI Lab Valued at $6 Billion
We are pleased to introduce Hark to our investors. The company develops its own foundational AI models alongside the consumer devices designed to run them.
Pre-IPO
Revolut received its sixth banking license and applied for a seventh the very next day
Colombia’s financial regulator, the SFC, has granted Revolut an operating license—the final authorization needed for launch.
Pre-IPO
Crusoe has opened a second plant in Tulsa, bringing the company's U.S. manufacturing footprint to 1 million square feet
The new Oklahoma facility added 400,000 square feet of space. Both Tulsa plants manufacture electrical components for AI infrastructure: medium-voltage switc...
Pre-IPO
Lovable revalued up 21% for the quarter, now at $16 billion
We have revalued Lovable today following the increase in the company's market capitalization. At the time of the previous revaluation—about a quarter ago—it ...
Pre-IPO
Lovable has switched to Fable 5.1 - code edits are 17% more accurate and a third cheaper
On September 1, Anthropic released Fable 5.1, a new model designed for coding and long-running tasks. That same day, Lovable announced it was building applic...
Pre-IPO
Crusoe Valuation Before IPO: What Investors Should Understand About Price vs. Hype
Crusoe valuation before IPO — analyzing deal price, expectations, and risk in private markets.
Pre-IPO
Secondary Market Risks for Private Investors: What Can Go Wrong with Private Shares
Secondary market risks for private shares — what can go wrong with liquidity, price, and access in pre-IPO deals.
